| Financial Year |
March 31 2023 |
| Monetary Funds |
1,843,093,934.94 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
99,644,384.37 |
| Advances to Suppliers |
392,444,295.02 |
| Other Receivables |
7,144,129.41 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
1,418,773.41 |
| Inventories |
1,669,372,117.22 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
50,568,203.88 |
| Total Current Assets |
4,232,966,875.19 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
8,208,471.93 |
| Investment Properties |
-- |
| Fixed Assetes |
2,099,535,536.83 |
| Under-construction Projects |
221,020,595.14 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
367,510,025.79 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
98,617.11 |
| Deferred Income Tax Assets |
52,798,911.44 |
| Other Non-Current Assets |
47,122,055.96 |
| Sub-Total of Non-Current Assets |
2,845,934,144.74 |
| Total Assets |
7,078,901,019.93 |
| Short-Term Loans |
2,468,326,965.34 |
| Trading Financial liabilities |
-- |
| Notes Payable |
431,193,972.20 |
| Accounts Payable |
625,871,893.42 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
18,305,922.44 |
| Taxes Payable |
19,151,728.17 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
59,325,576.16 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
66,206,697.41 |
| Other Current Liabilities |
64,403,842.26 |
| Sub-Total of Current Liabilities |
4,458,328,369.57 |
| Long-term Loans |
561,532,817.53 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
23,897,656.18 |
| Deferred Income Tax Liabilities |
10,502,364.79 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
680,352,161.77 |
| Total Liabilities |
5,138,680,531.34 |
| Paid-In Capital(Or Share Stock) |
521,600,000.00 |
| Capital Surplus |
1,295,537,641.75 |
| Surplus Reserve |
135,040,899.29 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-147,075,245.21 |
| Minority Stockholder's Interest |
122,499,223.74 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,817,721,264.85 |
| Owner's Equity（Stockholder's Equity） |
1,940,220,488.59 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,078,901,019.93 |
